Juliet Thompson Non exec director5 Jan 2023 18:17
From Angle Plc RNS this morning.
Experienced life science executive, Juliet Thompson, joins ANGLE Board with immediate effect.
ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company, is delighted to announce that Juliet Thompson has been appointed as a Non-Executive Director of the Company, with effect from 5 January 2023.
Juliet has spent much of her career advising companies in the international life sciences sector, completing multiple financing and M&A transactions in Europe and the United States, helping companies raise in excess of US $4 billion to pursue their growth strategies. Juliet has held senior positions at WestLB Panmure and Stifel Europe and in 2003 was a co-founder of the specialist life science investment bank, Code Securities, later acquired by Nomura.
Juliet currently has a number of roles, including Non-Executive Board positions at Indivior plc, Novacyt SA and the private company, OrganOx. She chairs the Audit Committees of all three companies and is a member of the remuneration and nomination committees.
Juliet Thompson, commented:
"As a founder of two businesses and with a long track record advising companies, I understand the challenges faced by executive management teams of growth companies. I have specialist knowledge in the areas of financing, strategy and corporate governance and I look forward to bringing this experience to ANGLE as the Company looks to further advance its world leading position in CTC liquid biopsy."
With such experience maybe Juliet should be spending time helping JM with M&A etc etc !!!
Sign In
Follow the stocks
